OncoSec Medical Inc. promoted Christopher Twitty to the position of chief scientific officer.
Twitty joined OncoSec in 2016 as executive director of clinical science.
OncoSec Medical appoints chief scientific officer
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
OncoSec Medical Inc. promoted Christopher Twitty to the position of chief scientific officer.
Twitty joined OncoSec in 2016 as executive director of clinical science.